Platform Processes May Reduce AAV Gene Therapy Costs

被引:0
|
作者
Labant M.
机构
来源
关键词
D O I
10.1089/gen.44.04.16
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:42 / 44and46
页数:4404
相关论文
共 50 条
  • [1] Prednisolone and rapamycin reduce the plasma cell gene signature and may improve AAV gene therapy in cynomolgus macaques
    Kistner, Alexander
    Chichester, Jessica A.
    Wang, Lili
    Calcedo, Roberto
    Greig, Jenny A.
    Cardwell, Leah N.
    Wright, Margaret C.
    Couthouis, Julien
    Sethi, Sunjay
    McIntosh, Brian E.
    McKeever, Kathleen
    Wadsworth, Samuel
    Wilson, James M.
    Kakkis, Emil
    Sullivan, Barbara A.
    GENE THERAPY, 2024, 31 (3-4) : 128 - 143
  • [2] Prednisolone and rapamycin reduce the plasma cell gene signature and may improve AAV gene therapy in cynomolgus macaques
    Alexander Kistner
    Jessica A. Chichester
    Lili Wang
    Roberto Calcedo
    Jenny A. Greig
    Leah N. Cardwell
    Margaret C. Wright
    Julien Couthouis
    Sunjay Sethi
    Brian E. McIntosh
    Kathleen McKeever
    Samuel Wadsworth
    James M. Wilson
    Emil Kakkis
    Barbara A. Sullivan
    Gene Therapy, 2024, 31 : 128 - 143
  • [3] Safety and Tolerability of AAV in the Anterior Chamber: A Platform for Gene Therapy
    Lawrence, Matthew
    O'Callaghan, Jeffrey
    O'Connor, Merissa
    Chalberg, Tom
    Keravala, Annahita
    Campbell, Matthew
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [4] Scalable rHSV Platform Development for AAV Gene Therapy Vectors
    Garg, Nitin
    Sharma, Saurabh
    Knop, David R.
    MOLECULAR THERAPY, 2019, 27 (04) : 159 - 159
  • [5] Optimized AAV de novo synthesis platform for efficient AAV packaging to accelerate gene therapy programs
    Hurlimann, H.
    Yang, M.
    Rao, P.
    Koole, C.
    Karney, M.
    Richardson, C. M.
    Kumar, S.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A90 - A91
  • [6] Towards an AAV Platform Production Media and Process for the Gene and Cell Therapy Community
    Ndahiro, Nelson
    Sargunas, Justin
    Wen, Junneng
    Betenbaugh, Michael
    McNally, David
    Brakewood, William
    MOLECULAR THERAPY, 2024, 32 (04) : 282 - 283
  • [7] Engineered CHO cells as a novel AAV production platform for gene therapy delivery
    Nagy, Abdou
    Chakrabarti, Lina
    Kurasawa, James
    Mulagapati, Sri Hari Raju
    Devine, Paul
    Therres, Jamy
    Chen, Zhongying
    Schmelzer, Albert E.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [8] Exosome-Associated AAV as a Novel Platform for Gene Therapy of Hearing Loss
    Gyorgy, Bence
    Sage, Cyrille
    Scheffer, Deborah
    Indzhykulian, Artur A.
    Mu, Dakai
    Breakefield, Xandra O.
    Maguire, Casey A.
    Corey, David P.
    MOLECULAR THERAPY, 2015, 23 : S7 - S7
  • [9] Engineered CHO cells as a novel AAV production platform for gene therapy delivery
    Abdou Nagy
    Lina Chakrabarti
    James Kurasawa
    Sri Hari Raju Mulagapati
    Paul Devine
    Jamy Therres
    Zhongying Chen
    Albert E. Schmelzer
    Scientific Reports, 13
  • [10] New AAV serotypes may broaden the therapeutic pipeline to human gene therapy
    Flotte, TR
    MOLECULAR THERAPY, 2006, 13 (01) : 1 - 2